Episode Details
Back to Episodes
P3 Health Partners Q1 2026: Record Results & Strategic Growth
Description
P3 Health Partners soars in Q1 2026, reporting $26M adjusted EBITDA, surpassing expectations, with revenue at $386M, up from last year despite a smaller membership base. The company attributes success to focusing on high-performing markets, improved payer deals, flat medical cost trends, and a supportive macro shift. They raise full-year adjusted EBITDA outlook to $20M-$60M, fueled by momentum and a new Nebraska deal.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/760c4e120ed3e86c